Patent intelligence · EP
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
Patent details — EP 4302751
- Jurisdiction
- EP
- Status
- granted
- Grant date
- Jan 10, 2024
- Expiration
- Jan 5, 2044
- Applicant
- LTS LOHMANN THERAPIE SYSTEME AG [DE]
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 70 A I, A61K 31/ 137 A I, A61K 31/ 417 A I
Quick answer
EP 4302751 (ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT) is held by LTS LOHMANN THERAPIE SYSTEME AG [DE]. Status: granted. Granted Jan 10, 2024. Expires Jan 5, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LTS LOHMANN THERAPIE SYSTEME AG [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 70 A I, A61K 31/ 137 A I, A61K 31/ 417 A I, A61K 47/ 10 A I, A61K 47/ 20 A I
More from LTS LOHMANN THERAPIE SYSTEME AG [DE]
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted -
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
granted
Frequently asked questions
What is US patent 4302751?
EP 4302751 (ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT) is held by LTS LOHMANN THERAPIE SYSTEME AG [DE]. Status: granted. Granted Jan 10, 2024. Expires Jan 5, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 4302751?
LTS LOHMANN THERAPIE SYSTEME AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does EP 4302751 expire?
Our index shows an expiration date of Jan 5, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.